Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Cited by (1,010)

Items 801–900 of 1,010

1. Immunomodulatory Effects of Radiotherapy
   Sharda Kumari, Shibani Mukherjee, Debapriya Sinha, Salim Abdisalaam, Sunil Krishnan, Aroumougame Asaithamby · 2020 · International Journal of Molecular Sciences
2. Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives
   Chen Lung Huang, Jiayi Li, Ruiyan Wu, Yangqian Li, Chenliang Zhang · 2025 · Molecular Cancer
3. Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying Cells
   Thomas S. Griffith, Thomas A. Ferguson · 2011 · Immunity
4. Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist
   In Duk Jung, Soo Kyung Jeong, Chang-Min Lee, Kyung Tae Noh, Deok Rim Heo, Yong Kyoo Shin, Cheol‐Heui Yun, Won‐Jung Koh, Shizuo Akira, Jake Whang et al. · 2011 · Cancer Research
5. Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6
   Guoshuai Cao, Jian Wang, Xiaodong Zheng, Haiming Wei, Zhigang Tian, Rui Sun · 2015 · Journal of Biological Chemistry
6. Trial Watch
   Erika Vacchelli, Ilio Vitale, Éric Tartour, Alexander M.M. Eggermont, Catherine Sautès‐Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2013 · OncoImmunology
7. Inhibiting the CD8+ T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance
   Haiyan Chen, Lei Xu, Linfeng Li, Xiaoxing Liu, Jianxin Gao, Yongrui Bai · 2018 · Scientific Reports
8. Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities
   Ariel E. E. Marciscano, Adriana Haimovitz‐Friedman, Percy P. Lee, Phuoc Tho Tran, Wolfgang A. Tomé, Chandan Guha, Feng‐Ming Kong, Arjun Sahgal, Issam El Naqa, Andreas Rimner et al. · 2019 · International Journal of Radiation Oncology*Biology*Physics
9. The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation
   Chuanhui Han, Victoria Godfrey, Zhida Liu, Yanfei Han, Longchao Liu, Hua Peng, Ralph R. Weichselbaum, Hasan Zaki, Yang‐Xin Fu · 2021 · Science Immunology
10. Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker
    Anastasios I. Birmpilis, Antonios Paschalis, Apostolis Mourkakis, Panayiota Christodoulou, Ioannis V. Kostopoulos, Elina Antimissari, Georgia I. Terzoudi, Alexandros G. Georgakilas, Christina Armpilia, Panagiotis Papageorgis et al. · 2022 · Cells
11. Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
    Jianfeng Guo, Yifang Zou, Leaf Huang · 2023 · Small Methods
12. Spatiotemporal local and abscopal cell death and immune responses to histotripsy focused ultrasound tumor ablation
    Ashley Pepple, Joey Guy, Reliza J. McGinnis, Amy E. Felsted, Brian Song, Ryan T. Hubbard, Tejaswi Worlikar, Hannah Garavaglia, Joe Dib, Hannah Chao et al. · 2023 · Frontiers in Immunology
13. Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
    Yonghyun Lee, Jongyoon Shinn, Cheng Xu, Hannah E. Dobson, Nouri Neamati, James Jaehyun Moon · 2023 · Nature Communications
14. Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
    Koji Kono, Kosaku Mimura, Rolf W. Kiessling · 2013 · Cell Death and Disease
15. Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity
    Chen, G.-Y., Brown, N. K., Zheng, P., Liu, Y. · 2014 · Glycobiology
16. Type I IFN activating type I dendritic cells for antitumor immunity
    Liang, Yong, Hannan, Raquibul, Fu, Yang-Xin · 2021 · Clinical Cancer Research
17. Delivery Strategies for Immune Checkpoint Blockade
    Chen, Qian, Wang, Chao, Chen, Guojun, Hu, Quanyin, Gu, Zhen · 2018 · Advanced Healthcare Materials
18. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
    Aranda, F, Bloy, N, Pesquet, J, Petit, B, Chaba, K, Sauvat, A, Kepp, O, Khadra, N, Enot, D, Pfirschke, C et al. · 2015 · Oncogene
19. Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
    Tetje Cornelia van der Sluis, Suzanne van Duikeren, Suzanna Huppelschoten, Ekaterina S. Jordanova, Elham Beyranvand Nejad, Arjen Sloots, Louis Boon, Vincent T.H.B.M. Smit, Marij J.P. Welters, FERRY A. OSSENDORP et al. · 2014 · Clinical Cancer Research
20. The Optimal Partnership of Radiation and Immunotherapy: from Preclinical Studies to Clinical Translation
    Sandra Demaria, Karsten A. Pilones, Claire Vanpouille‐Box, Encouse B. Golden, Silvia Chiara Formenti · 2014 · Radiation Research
21. Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer
    Yang Xiong, Ying Wang, Karthik Tiruthani · 2019 · Nanomedicine Nanotechnology Biology and Medicine
22. Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer
    Bianca Oresta, Chiara Pozzi, Daniele Braga, Rodolfo Fausto Hurle, Massimo Lazzeri, Piergiuseppe Colombo, Nicola Frego, Marco Erreni, Cristina Faccani, Grazia Maria Elefante et al. · 2021 · Science Translational Medicine
23. Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
    Røssevold, Andreas Hagen, Andresen, Nikolai Kragøe, Bjerre, Christina Annette, Gilje, Bjørnar, Jakobsen, Erik Hugger, Raj, Sunil Xavier, Falk, Ragnhild Sørum, Russnes, Hege Giercksky, Jahr, Thea, Mathiesen, Randi Ruud et al. · 2022 · Nature Medicine
24. Toll-Like Receptors, Tissue Injury, and Tumourigenesis
    Savvas Ioannou, Michael Voulgarelis · 2010 · Mediators of Inflammation
25. Role of toll-like receptors in tissue repair and tumorigenesis
    Seth Rakoff-Nahoum, Ruslan M. Medzhitov · 2008 · Biochemistry (Moscow)
26. Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
    Kelly Kersten, Camilla Salvagno, Karin E. de Visser · 2015 · Frontiers in Immunology
27. Tumors Sound the Alarmin(s)
    Seth B. Coffelt, Aline B. Scandurro · 2008 · Cancer Research
28. Melatonin as an anti-inflammatory agent in radiotherapy
    Masoud Najafi, Alireza Shirazi, Elahe Motevaseli, Abolhasan Rezaeyan, Ashkan Salajegheh, Saeed Rezapoor · 2017 · Inflammopharmacology
29. Extracorporeal photochemotherapy induces bona fide immunogenic cell death
    Kazuki Tatsuno, Takahiro Yamazaki, Douglas J. Hanlon, Patrick Han, Eve Robinson, Olga Sobolev, Alp Yurter, Félix E. Rivera-Molina, Najla Arshad, Richard L. Edelson et al. · 2019 · Cell Death and Disease
30. Oxaliplatin and its derivatives – An overview
    Paul O'Dowd, Darragh F. Sutcliffe, Darren M. Griffith · 2023 · Coordination Chemistry Reviews
31. DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
    Jennifer L. Guerriero, Dara Ditsworth, Joseph M. Catanzaro, Gregory J. Sabino, Martha B. Furie, Richard R. Kew, Howard C. Crawford, Wei‐Xing Zong · 2011 · The Journal of Immunology
32. Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
    Alice Hervieu, Cédric Rébé, Frédérique Végran, Fanny Chalmin, Mélanie Bruchard, Pierre Vabres, Lionel Apétoh, François Ghiringhelli, Grégoire Mignot · 2012 · Journal of Investigative Dermatology
33. Toll-like receptors: roles in neuroprotection?
    Uwe‐Karsten Hanisch, Thomas V. Johnson, Jonathan Kipnis · 2008 · Trends in Neurosciences
34. Tumor stress, cell death and the ensuing immune response
    Evelyn Ullrich, Mathieu Bonmort, Grégoire Mignot, Guido Kroemer, Laurence Zitvogel · 2007 · Cell Death and Differentiation
35. Sensing of cell death by myeloid C-type lectin receptors
    David Sancho, Caetano Reis e Sousa · 2013 · Current Opinion in Immunology
36. Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
    Dalil Hannani, Antonella Sistigu, Oliver Kepp, Lorenzo Galluzzi, Guido Kroemer, Laurence Zitvogel · 2011 · The Cancer Journal
37. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Anurag K. Singh, Timothy B. Winslow, Mohammad Habiby Kermany, Vincent Goritz, Lilia Heit, Austin Miller, Nicholas C. Hoffend, Leighton C. Stein, Lalith K. Kumaraswamy, Graham Walter Warren et al. · 2017 · Clinical Cancer Research
38. Immune recognition of irradiated cancer cells
    Erik Wennerberg, Claire Vanpouille‐Box, Sophia Bornstein, Takahiro Yamazaki, Sandra Demaria, Lorenzo Galluzzi · 2017 · Immunological Reviews
39. Immunotherapy in hepatocellular carcinoma
    Luigi Buonaguro, Angela Mauriello, Beatrice Cavalluzzo, Annacarmen Petrizzo, Maria Tagliamonte · 2019 · Annals of Hepatology
40. Effective Radiotherapy in Tumor Assisted by Ganoderma lucidum Polysaccharide-Conjugated Bismuth Sulfide Nanoparticles through Radiosensitization and Dendritic Cell Activation
    Huan Yu, Yang Yang, Tianyan Jiang, Xihui Zhang, Yuhao Zhao, Guibin Pang, Yahui Feng, Shulei Zhang, Fujun Wang, Yong Wang et al. · 2019 · ACS Applied Materials & Interfaces
41. TNF‐α and IL‐1β sensitize human MSC for IFN‐γ signaling and enhance neutrophil recruitment
    Alexander Maximilian Hackel, Aleksandra Aksamit, Kirsten Bruderek, Stephan Lang, Sven Brandau · 2020 · European Journal of Immunology
42. Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity
    Dayson Moreira, Sagus Sampath, Haejung Won, Seok Voon White, Yu‐Lin Su, Marice B. Alcantara, Chongkai Wang, Peter P. Lee, Ellie G. Maghami, Erminia Massarelli et al. · 2020 · Journal of Clinical Investigation
43. From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy
    Liufu Deng, Hua Laura Liang, Sherry Fu, Ralph R. Weichselbaum, Yang‐Xin Fu · 2015 · Clinical Cancer Research
44. TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
    Chan Gao, Anna Karolina Kozłowska, Sergey Nechaev, Haiqing Li, Qifang Zhang, Dewan Md Sakib Hossain, Claudia M. Kowolik, Peiguo G. Chu, Piotr M. Swiderski, Don J. Diamond et al. · 2013 · Cancer Research
45. Lung cancer: potential targets for immunotherapy
    Éric Tartour, Laurence Zitvogel · 2013 · The Lancet Respiratory Medicine
46. Immune-priming of the Tumor Microenvironment by Radiotherapy
    Vafa Shahabi, Michael A. Postow, David P. Tuck, Jedd D. Wolchok · 2013 · American Journal of Clinical Oncology
47. Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma
    Cristina Trejo‐Solís, Norma Serrano‐García, Ángel Escamilla-Ramírez, Rosa Angélica Castillo‐Rodríguez, Dolores Jiménez‐Farfán, Guadalupe Palencia, Minerva Calvillo, Mayra Angélica Alvarez Lemus, Athenea Flores‐Nájera, Arturo Cruz-Salgado et al. · 2018 · International Journal of Molecular Sciences
48. Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
    Mahesh Chandra Patra, Masaud Shah, Sangdun Choi · 2019 · Seminars in Cancer Biology
49. Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives
    Benjamin N. Forgie, Rewati Prakash, Carlos Marcelo Telleria · 2022 · International Journal of Molecular Sciences
50. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma
    Dehua Wu, Yanqing Ding, S Wang, Q Zhang, Li Liu · 2008 · The Journal of Pathology
51. Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
    Sylvia Adams, A. Bapsi Chakravarthy, Martin Edward Donach, DARCY V. SPICER, Stella C. Lymberis, Baljit Singh, Joshua A. Bauer, Tsivia Hochman, Judith D. Goldberg, Franco M. Muggia et al. · 2010 · Breast Cancer Research and Treatment
52. Haematological malignancies: at the forefront of immunotherapeutic innovation
    Bachireddy, Pavan, Burkhardt, Ute E., Rajasagi, Mohini, Wu, Catherine J. · 2015 · Nature Reviews Cancer
53. The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
    Shi, Congqi, Qin, Kaiyu, Lin, Anqi, Jiang, Aimin, Cheng, Quan, Liu, Zaoqu, Zhang, Jian, Luo, Peng · 2022 · Journal of Experimental & Clinical Cancer Research
54. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer
    Zishuo I. Hu, Alice Y. Ho, Heather L. McArthur · 2017 · International Journal of Radiation Oncology*Biology*Physics
55. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
    Russell Maxwell, Christopher Mitchell Jackson, Michael K. Lim · 2017 · Current Treatment Options in Oncology
56. Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis
    Ghanyah H. Al-Qadami, Ysabella Z. A. Van Sebille, Hien V. Le, Joanne M. Bowen · 2019 · Expert Review of Gastroenterology & Hepatology
57. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition
    Rongrong Zheng, Linping Zhao, Chu‐Yu Huang, Hong Bo Cheng, Yang Ni, Zu‐Xiao Chen, Hua Cai, Wei Zhang, Renjiang Kong, Shiying Li · 2023 · ACS Nano
58. The Janus face of dendritic cells in cancer
    Nathalie Chaput, Rosa Conforti, Sophie Viaud, Alan Spatz, Laurence Zitvogel · 2008 · Oncogene
59. Enhancing the clinical activity of granulocyte‐macrophage colony‐stimulating factor‐secreting tumor cell vaccines
    Masahisa Jinushi, Frank Stephen Hodi, Glenn Dranoff · 2008 · Immunological Reviews
60. ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
    Michael R. Shurin, Hiam Naiditch, Dmitriy W. Gutkin, Viktor Umansky, Galina V. Shurin · 2012 · Current Medicinal Chemistry
61. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
    Yuta Shibamoto, AKIFUMI MIYAKAWA, S. Otsuka, Hiromitsu Iwata · 2016 · Journal of Radiation Research
62. Combining PARP Inhibition, Radiation, and Immunotherapy: A Possible Strategy to Improve the Treatment of Cancer?
    Mathieu Césaire, Juliette Thariat, Serge M. Candéias, Dinu Stefan, Yannick Saintigny, François Chevalier · 2018 · International Journal of Molecular Sciences
63. Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality
    Eric C. Ko, Silvia Chiara Formenti · 2019 · International Journal of Radiation Biology
64. Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer
    Christine H. Feng, Loren K. Mell, Andrew B. Sharabi, Michael T McHale, Jyoti Mayadev · 2020 · Seminars in Radiation Oncology
65. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer
    Wenxi Zhou, Xinli Chen, Yu Zhou, Si Shi, Chen Liang, Xianjun Yu, Hongyi Chen, Qin Guo, Yiwen Zhang, Peixin Liu et al. · 2021 · Biomaterials
66. Harnessing the immune response to treat cancer
    Henry John Steer, Richard Lake, Anna K. Nowak, Bruce W.S. Robinson · 2010 · Oncogene
67. Inflammasome: Cancer's friend or foe?
    Michela Terlizzi, Vincenzo Casolaro, Aldo Pinto, Rosalinda Sorrentino · 2014 · Pharmacology & Therapeutics
68. Mechanisms Involved in Radiation Enhancement of Intratumoral Dendritic Cell Therapy
    Seagal Teitz‐Tennenbaum, Qiao Li, Ryuji Okuyama, Mary A. Davis, Rong Sun, Joel R. Whitfield, Randall N. Knibbs, Lloyd M. Stoolman, Alfred E. Chang · 2008 · Journal of Immunotherapy
69. Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells
    Raquel Aguilera, Carlos Saffie, Andrés Tittarelli, Fermín Eduardo González, Marcos Ramírez, Diego Reyes, Cristián Pereda, Daniel Hevia, Tamara García‐Salum, Lorena Salazar et al. · 2011 · Clinical Cancer Research
70. Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner
    Timothy J. Harris, Edward L. Hipkiss, Scott Borzillary, Satoshi Wada, Joseph F. Grosso, Hung‐Rong Yen, Derese Getnet, Tullia Carmela Bruno, Monica V. Goldberg, Drew M. Pardoll et al. · 2008 · The Prostate
71. Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin)
    Mamoru Tanaka, Hiromi Kataoka, Shigenobu Yano, Takuya Sawada, Haruo Akashi, Masahiro Inoue, Shugo Suzuki, Yusuke Inagaki, Noriyuki Hayashi, Hirotada Nishie et al. · 2016 · Oncotarget
72. Cancer Treatment with Gene Therapy and Radiation Therapy
    S. Kaliberov, D. Buchsbaum · 2012 · Advances in Cancer Research
73. Desirable cell death during anticancer chemotherapy
    Clara Locher, Rosa Conforti, Laetitia Aymeric, Yuting Ma, Takahiro Yamazaki, Sylvie Rusakiewicz, Antoine Tesnière, François Ghiringhelli, Lionel Apétoh, Yannis Morel et al. · 2010 · Annals of the New York Academy of Sciences
74. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
    Oliver J. Stoetzer, Debora M.I. Fersching, Christoph Salat, Oliver Steinkohl, Christian J. Gabka, Ulrich Hamann, Michael Braun, Axel Mario Feller, Volker Heinemann, Barbara Siegele et al. · 2012 · Tumor Biology
75. How to improve the immunogenicity of chemotherapy and radiotherapy
    Yuting Ma, Rosa Conforti, Laetitia Aymeric, Clara Locher, Oliver Kepp, Guido Kroemer, Laurence Zitvogel · 2011 · Cancer and Metastasis Reviews
76. Doxorubicin prodrug-based nanomedicines for the treatment of cancer
    Haibo Zhao, Jing Yu, Renshuai Zhang, Pengwei Chen, Hongfei Jiang, Wanpeng Yu · 2023 · European Journal of Medicinal Chemistry
77. Building immunity to cancer with radiation therapy
    Suresh J. Haikerwal, Jim Hagekyriakou, Michael Patrick MacManus, Olga A. Martin, Nicole M. Haynes · 2015 · Cancer Letters
78. Cancer vaccines: on the threshold of success
    Leisha A. Emens · 2008 · Expert Opinion on Emerging Drugs
79. Impact of Toll-like receptor 4 polymorphisms on risk of cancer
    Anton G. Kutikhin · 2010 · Human Immunology
80. Pathogen recognition receptors, cancer and inflammation in the gut
    Masayuki Fukata, Maria Teresa Abreu · 2009 · Current Opinion in Pharmacology
81. T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
    Jianfeng Liu, Si‐Rui Ma, Liang Mao, Lin‐Lin Bu, Guang‐Tao Yu, Yicun Li, Cong‐Fa Huang, Wei‐Wei Deng, Ashok B. Kulkarni, Wen‐Feng Zhang et al. · 2017 · Molecular Oncology
82. Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
    Manabu Kaneko, Hiroaki Nozawa, Kazuhito Sasaki, Kumiko Hongo, Masaya Hiyoshi, Noriko Tada, Koji Murono, Takako Nirei, Kazushige Kawai, Eiji Sunami et al. · 2012 · Oncology
83. BiO 2– x Nanosheets as Radiosensitizers with Catalase-Like Activity for Hypoxia Alleviation and Enhancement of the Radiotherapy of Tumors
    Huimin Liu, Ran Cheng, Xinghua Dong, Shuang Zhu, Ruyi Zhou, Liang Yan, Chenyang Zhang, Qing Wang, Zhanjun Gu, Yuliang Zhao · 2020 · Inorganic Chemistry
84. Protein-Based Nanomedicine for Therapeutic Benefits of Cancer
    Qiuhong Zhang, Junmin Zhang, Jun Song, Yizhen Liu, Xiangzhong Ren, Yanli Zhao · 2021 · ACS Nano
85. Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response
    Amarilis Pérez-Baños, María Alejandra Gleisner, Iván Flores, Cristián Pereda, Mariela Navarrete, Juan Pablo Araya, Giovanna Navarro, Claudia Quezada-Monrás, Andrés Tittarelli, Flavio Salazar‐Onfray · 2023 · British Journal of Cancer
86. Role for MyD88, TLR2 and TLR9 but Not TLR1, TLR4 or TLR6 in Experimental Autoimmune Encephalomyelitis
    S. Miranda-Hernandez, N. Gerlach, J. Fletcher, E. Biros, M. Mack, H. Körner, A. Baxter · 2011 · Journal of Immunology
87. Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity
    Zuqiang Liu, Louis D. Falo, Zhaoyang You · 2011 · The Journal of Immunology
88. HPV-induced oropharyngeal cancer, immune response and response to therapy
    Ha Linh Vu, Andrew Gregory Sikora, Shibo Fu, Johnny Kao · 2009 · Cancer Letters
89. Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy
    Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, P Stieber, Stefan Holdenrieder · 2012 · Tumor Biology
90. Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
    Hanna Lee, Meiying Song, Nara Shin, Chang Hoon Shin, Byung Soh Min, Hyon-Suk Kim, Jong Shin Yoo, Hoguen Kim · 2012 · PLoS ONE
91. Prothymosin-α inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction
    Arevik Mosoian, Avelino V. Teixeira, Colin Burns, Leif Erik Sander, Gabriele Luca Gusella, Cijiang He, Julie Magarian Blander, Paul E. Klotman, Mary E. Klotman · 2010 · Proceedings of the National Academy of Sciences
92. Immunotherapy and the Interventional Oncologist: Challenges and Opportunities—A Society of Interventional Oncology White Paper
    Joseph Patrick Erinjeri, G Fine, Gosse J. Adema, Muneeb Ahmed, Julius Chapiro, Martijn H. den Brok, Rafael Durán, Stephen James Hunt, D. Johnson, Jens Ricke et al. · 2019 · Radiology
93. Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non–Small-cell Lung Cancer: A Mini-review
    Shinkichi Takamori, Gouji Toyokawa, Kazuki Takada, Fumihiro Shoji, Tatsuro Okamoto, Yoshihiko Maehara · 2017 · Clinical Lung Cancer
94. The Radiobiology of Radiopharmaceuticals
    Zachary Scott Morris, Andrew Zhuang Wang, Susan Jane Knox · 2020 · Seminars in Radiation Oncology
95. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
    Marine Fidelle, Satoru Yonekura, Marion Picard, Alexandria P. Cogdill, Antoine Hollebecque, María Paula Roberti, Laurence Zitvogel · 2020 · Frontiers in Immunology
96. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
    Jing Qi, Feiyang Jin, Xiaoling Xu, Yongzhong Du · 2021 · International Journal of Nanomedicine
97. HMGB1 and its physiological and pathological roles
    H. Naglova, Mária Bucová · 2012 · Bratislavské lekárske listy/Bratislava medical journal
98. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
    Mickaël Michaud, Xiaoqi Xie, José Manuel Bravo‐San Pedro, Laurence Zitvogel, Eileen White, Guido Kroemer · 2014 · OncoImmunology
99. The dendritic cell–tumor cross-talk in cancer
    Yuting Ma, Laetitia Aymeric, Clara Locher, Guido Kroemer, Laurence Zitvogel · 2010 · Current Opinion in Immunology
100. Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
     Zuozhang Yang, Zhenyi Su, Judy Park DeWitt, Lin Xie, Yongbin Chen, Xiaojuan Li, Lei Han, Dongqi Li, Junfeng Xia, Ya Zhang et al. · 2017 · EBioMedicine